Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7B consumer brands deal

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
StockStory.org on MSN

Kforce’s (NYSE:KFRC) Q3 Sales Beat Estimates, Stock Jumps 14.1%

Professional staffing firm Kforce (NYSE:KFRC) announced in Q3 CY2025, but sales fell by 5.9% year on year to $332.6 million.

Canadian Pacific Kansas City: Initiating A Buy Following Q3 Results

Discover why Canadian Pacific Kansas City’s unique rail network and strong earnings growth make it a top Buy for investors.

Crane Harbor Stock Rise on Merger Deal with Xanadu Quantum Technologies

Crane Harbor Acquisition Corp (NASDAQ:CHAC) rose Monday after the company announced a merger deal with Xanadu Quantum Technologies to form a dedicated photonic quantum computing firm.

Kimberly-Clark to Buy Tylenol Maker Kenvue. Why Kimberly-Clark Stock Is Tanking.

Kimberly-Clark agreed to buy Kenvue in a cash-and-stock transaction that values the Tylenol maker at an enterprise value of ...

Why Kimberly-Clark Stock Just Dropped

Kimberly-Clark is promising to pay Kenvue shareholders $3.50 in cash, plus 0.14625 Kimberly-Clark shares, for each Kenvue ...